Actelion Ltd.

Actelion Ltd.

Actelion Ltd.

Overview
Date Founded

1999

Headquarters

Gewerbestrasse 16, Allschwil, CH-4123, CHE

Type of Company

Private

Employees (Worldwide)

2,547

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Biotechnology

Company Description

Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.

Contact Data
Trying to get in touch with decision makers at Actelion Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Senior Vice President & Group General Counsel

Chief Business Development Officer & Executive Vice President

Co-Founder

Global Head

Head, Global Human Resources

Director, Corporate Communications

Professional

Board of Directors

Senior Vice President & Group General Counsel at Actelion Ltd.

Paths to Actelion Ltd.
Potential Connections via
Relationship Science
You
Actelion Ltd.
Recent Transactions
Details Hidden

Johnson & Johnson purchases Actelion Ltd.

Details Hidden

purchases Idorsia Ltd. from Actelion Ltd.

Details Hidden

Actelion US Holding Co., Actelion Ltd. purchase Ceptaris Therapeutics, Inc.

Transaction Advisors
Accountant

Advised onActelion Ltd. purchases Axovan AG

Legal Advisor

Advised onJohnson & Johnson purchases Actelion Ltd.

Investment Advisor

Advised onJohnson & Johnson purchases Actelion Ltd.

Legal Advisor

Advised onJohnson & Johnson purchases Actelion Ltd.

Legal Advisor

Advised onJohnson & Johnson purchases Actelion Ltd.

Attorney

Advised onJohnson & Johnson purchases Actelion Ltd.

Advisors & Consultants
Legal Advisor

Managing Partner at Dechert LLP

Senior Advisor

Former Senior Vice President, Head-Investor Relations & Public Affairs at Actelion Ltd.

Clients

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on 2013 and is headquartered in North Chicago, IL.

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment conducts certain manufacturing, quality assurance, R&D and administration functions. The Generic Pharmaceuticals segment conducts certain manufacturing, distribution, quality assurance and administration functions, as well as certain R&D functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.

Key Stats and Financials As of
Market Capitalization
$31.2B
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

General Partner at Sofinnova Investments, Inc.

Suppliers
Johnson & Johnson Biotechnology | New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Roche Holding AG Hospitals & Patient Services | Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

UCB S. A. Pharmaceuticals

UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Actelion Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Actelion Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Actelion Ltd..